Seller record · Telehealth service

Brightmeds

By Paul Harris, Standards EditorRecorded September 2026 · Standard v1.1 · How checks are performed

Fails 2 of 8 criteria. S5, analytical documentation: No certificate of analysis or lot document is published on the price pages, the answers, the terms or the privacy policy. 1 more criterion also fails; see the table below.

At a glance

BrightmedsTelehealth service

6/8criteria passed

Price: Semaglutide $129 a month or $99 on a 3-month pack, tirzepatide $149
Sells: compounded semaglutide, compounded tirzepatide, semaglutide microdosing, and 6 more
FDA letters: None on file

Visit Brightmeds See all eight dispositions

Telehealth service. Passes 6 of 8 criteria. Recorded against Standard v1.1.

A telehealth service selling compounded semaglutide and tirzepatide, including microdose plans, with sermorelin, NAD+ and glutathione injections, testosterone care and brand Zepbound through a doctor consult. It prints flat monthly prices for every dose and names two filling pharmacies in its terms, and it publishes no street address.

Operating entity Brightmeds LLC

Dispositions

Code	Criterion	Disposition	Where it appears
S1	Prescriber requirement	PASS	Brightmeds' website; Brightmeds' about page
S2	Prescription gating	PASS	Brightmeds' GLP-1 semaglutide page; Brightmeds' website
S3	Pharmacy identification	PASS	Brightmeds' terms
S4	Compounding disclosure	PASS	Brightmeds' website; Brightmeds' summer special page
S5	Analytical documentation	FAIL	Brightmeds' summer special page; Brightmeds' terms; Brightmeds' privacy policy
S6	Business address	FAIL	Brightmeds' contact page; Brightmeds' terms; Brightmeds' privacy policy
S7	Price disclosure	PASS	Brightmeds' summer special page; Brightmeds' summer special sermorelin page; Brightmeds' summer special NAD+ plus page; Brightmeds' summer special glutathione page; Brightmeds' products page
S8	Enforcement status	PASS	FDA warning-letter index

Evidence, criterion by criterion

The evidence behind each disposition in the table above, where it appears, and its date.

S1PASSA licensed U.S. physician reviews each health profile and decides whether the buyer is eligible, and treatments are prescribed and monitored by board-certified physicians.Source: Brightmeds' website; Brightmeds' about page.

S2PASSThe start button opens an intake whose first screen asks the buyer's weight loss goal, and the site says a buyer who is not approved is refunded in full.Source: Brightmeds' GLP-1 semaglutide page; Brightmeds' website.

S3PASSThe terms name two filling pharmacies, Southend Pharmacy and Red Rock Pharmacy, and say the list is not exclusive. No city, state or street address is printed for either.Source: Brightmeds' terms.

S4PASSThe answers on the home page state that compounded drugs are not FDA-approved, and each price page repeats that compounded medications are not reviewed or approved by the FDA.Source: Brightmeds' website; Brightmeds' summer special page.

S5FAILNo certificate of analysis or lot document is published on the price pages, the answers, the terms or the privacy policy.Source: Brightmeds' summer special page; Brightmeds' terms; Brightmeds' privacy policy.

S6FAILNo street address is printed. The contact page gives only an email address, and the footer, the terms and the privacy policy name Brightmeds LLC with no address.Source: Brightmeds' contact page; Brightmeds' terms; Brightmeds' privacy policy.

S7PASSCompounded semaglutide at $129 a month month to month, or $99 a month on a 3-month pack billed $297 at once, and compounded tirzepatide at $149 a month, or $119 a month on the pack billed $357, at any dose. Sermorelin and the NAD+ injection at $129 a month and glutathione at $99 a month, month to month, each page stating the price does not rise later. Zepbound through a $100 doctor consult fee, with the medication paid to the pharmacy separately.Source: Brightmeds' summer special page; Brightmeds' summer special sermorelin page; Brightmeds' summer special NAD+ plus page; Brightmeds' summer special glutathione page; Brightmeds' products page.

S8PASSNo FDA warning letter names Brightmeds or Brightmeds LLC, and no action has halted the business.Source: FDA warning-letter index.

Products shown on the seller's own pages at the recorded date: compounded semaglutide, compounded tirzepatide, semaglutide microdosing, tirzepatide microdosing, brand Zepbound pens and vials, sermorelin, NAD+ injection, glutathione injection, testosterone replacement.

Other sellers of the same products

Who sells semaglutide Who sells tirzepatide Who sells sermorelin Who sells NAD+Who sells glutathione

Visit Brightmeds

Dispositions recorded against Standard v1.1. Method and null semantics: how checks are performed. This record is not a review and contains no medical advice.